Key points are not available for this paper at this time.
Abstract Background End-stage renal disease is the last stage of chronic kidney disease. It is estimated that by 2030 more than 70% of patients with end-stage renal disease would be living in low-income countries. The aim of this study was to analyze the survival time and its determinants among patients with end stage renal disease in Eastern, Ethiopia. Method A retrospective cohort study design was employed to analyze the survival time and its determinants among 754 end stage renal disease patients with hemodialysis follow up between September 1/2015 and August 30/2020 in Eastern Ethiopia. Data was collected from patients chart using listing questionnaire by 10 data collectors and analyzed using STATA version 14. Frequency tables and Kaplan-Meier graphs were used to describe the characteristic of the data, while the Weibull regression model was employed at 5% levels of significance to assess association between the covariates and the survival time of end stage renal disease patients. Result Among 754 hemodialysis patients, 176(23.3%) were died. The overall median survival time of patients in the five year follow up period was 40.695%CI: 38.54, 43.8 months, with a mortality rate of 5.84 95%CI: 5.04, 6.77 per 1000 person-months. In the Weibull regression model, urban area HR = 6.61, 95%CI: 2.67, 16.36, being widowed HR = 13.11, 95%CI:10.79, 16.09, having family history of RD HR = 1.42, 95%CI: 1.02, 2.97 and using central venous catheters vascular access HR = 2.52, 95%CI: 1.34, 4.34 were significantly associated with increased risk of death, while having follow up in Sheik Hassen hospital HR = 0.48, 95%CI: 0.26, 0.58, three times dialysis per week HR = 0.21, 95%CI: 0.09, 0.49, 4 dialysis hours per session HR = 0.26, 95%CI: 0.11, 0.63, and higher Kt/v level HR = 0.30, 95%CI: [0.11, 0.80 were significantly associated with lower risk of death. Conclusion The median survival time of patients was lower than other studies. AV fistula should be also adapted as dialysis modality.
Fiseha et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: